|
EIF2C1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.061900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.16530000052684E-07 |
| Normal-vs-Stage2 |
7.212800E-01 |
| Normal-vs-Stage3 |
4.006200E-01 |
| Normal-vs-Stage4 |
7.508000E-01 |
| Stage1-vs-Stage2 |
3.379100E-03 |
| Stage1-vs-Stage3 |
1.219560E-04 |
| Stage1-vs-Stage4 |
4.89169999950967E-07 |
| Stage2-vs-Stage3 |
7.662400E-01 |
| Stage2-vs-Stage4 |
5.394600E-01 |
| Stage3-vs-Stage4 |
2.820800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.361700E-04 |
| Normal-vs-AfricanAmerican |
7.757400E-01 |
| Normal-vs-Asian |
1.400190E-01 |
| Caucasian-vs-AfricanAmerican |
1.487850E-02 |
| Caucasian-vs-Asian |
1.002610E-01 |
| AfricanAmerican-vs-Asian |
1.303990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.323700E-02 |
| Normal-vs-Female |
1.019070E-04 |
| Male-vs-Female |
2.020500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.443200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.382300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.922400E-02 |
| Normal-vs-Age(81-100Yrs) |
9.375000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.950800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.374200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.755800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.950200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.730300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.733400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.5489299999949E-05 |
| Normal-vs-Grade 2 |
7.17839999997416E-07 |
| Normal-vs-Grade 3 |
7.163500E-02 |
| Normal-vs-Grade 4 |
1.096230E-01 |
| Grade 1-vs-Grade 2 |
1.401400E-01 |
| Grade 1-vs-Grade 3 |
6.944600E-03 |
| Grade 1-vs-Grade 4 |
1.32440000000233E-06 |
| Grade 2-vs-Grade 3 |
9.429100E-04 |
| Grade 2-vs-Grade 4 |
9.01779984019413E-10 |
| Grade 3-vs-Grade 4 |
8.826400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.29449850417541E-11 |
| Normal-vs-ccB subtype |
5.910200E-01 |
| ccA subtype-vs-ccB subtype |
1.36300004616174E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.048210E-02 |
| Normal-vs-N1 |
7.345400E-01 |
| N0-vs-N1 |
5.017200E-01 |
|
|
